DETROIT, Mich. – A long‑term study tracking over 2,700 women for two decades has found an association between menopause hormone therapy and a reduced risk of serious heart problems. The research, which focused on women without prior cardiovascular disease, offers encouraging data for families seeking relief from menopause symptoms while protecting heart health.
Key Findings
Women who began hormone therapy during the study experienced an estimated 22% lower rate of cardiovascular events—such as heart attacks and strokes—compared with those who did not use the treatment. Timing mattered: participants who started therapy within ten years of menopause saw an estimated 27% lower event rate.
The most pronounced benefit appeared among Black women, who showed an estimated 49% lower rate of cardiovascular events when using hormone therapy.
What the Study Shows
Because the study was observational, it identified a correlation rather than proving causation. Researchers noted that other factors—differences in lifestyle, health history, or access to care—could also influence the outcomes. Nonetheless, the data suggest that hormone therapy, when individualized and started early in the menopause transition, may contribute to better heart health.
Why Hormone Levels Matter
Menopause brings a dramatic decline in estrogen, a hormone that helps protect blood vessels and supports cardiovascular function. The loss of estrogen may partly explain why heart disease risk rises after menopause. Hormone therapy can restore some of these protective effects, potentially lowering the chance of heart attacks and strokes.
Considerations for Women
Hormone therapy remains an effective option for relieving common menopause symptoms—hot flashes, night sweats, and sleep disturbances—that affect up to 80% of women. Health professionals stress that decisions about therapy should be made on a case‑by‑case basis, weighing individual medical history, symptom severity, and personal risk factors.
Doctors, including family physicians and gynecologists, can help patients determine whether hormone therapy is appropriate, taking into account the timing of menopause, overall health, and any existing conditions.
Next Steps for Research
The study also highlighted that hormone formulations used two decades ago differ from many modern products. Further research is needed to confirm whether newer hormone therapies provide the same cardiovascular benefits.
While the findings are promising, they do not constitute a recommendation for women to start hormone therapy solely to prevent heart disease. Ongoing clinical trials and future observational work will help clarify the role of hormone therapy in cardiovascular protection.
What This Means for Families
For families navigating menopause, the study offers a hopeful perspective: effective symptom relief may also align with heart health goals, especially when treatment begins early. Parents and caregivers can support women in discussing options with trusted medical professionals, ensuring choices reflect both health needs and personal values.
Original reporting: WOWO News/Talk (Fort Wayne) — read the source article.
